References
Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med 2012; 366: 2492–2501.
Hiware S, Shrivastava M, Mishra D, Mukhi J, Puppalwar G. Evaluation of Cutaneous Drug Reactions in Patients Visiting Out Patient Departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur. Indian J Dermatol 2013; 58: 18–21.
Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F. Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy. Clin Neurol Neurosurg 2012; 114: 862–865.
Goldensohn ES, Hardie J, Borea ED. Ethosuximide in the treatment of epilepsy. JAMA 1962; 180: 840–842.
Kiorboe E, Paludan J, Trolle E, Overvad E. Zarontin (ethosuximide) in the treatment of petit mal and related disorders. Epilepsia 1964; 5: 83–89.
Penovich PE, Willmore LJ. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. Epilepsia 2009; 50(Suppl 8): 37–41.
Crespel A, Velizarova R, Agullo M, Gélisse P. Ethosuximideinduced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence. Epilepsia 2009; 50: 2003.
Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 1976; 57: 529–534.
Taaffe A, O’Brien C. A case of Stevens-Johnson syndrome associated with the anti-convulsants sulthiame and ethosuximide. Br Dent J 1975; 138: 172–174.
Pichler WJ. Adverse side-effects to biological agents. Allergy 2006; 61: 912–920.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ricci, F., Paradisi, A., Masini, F. et al. Acneiform eruption induced by ethosuximide. Eur J Dermatol 24, 98–99 (2014). https://doi.org/10.1684/ejd.2013.2220
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2013.2220